Neu Health Launches in U.S.
Supported by FDA Clearance for Parkinson’s Tremor Measurement
Delivering precision neurology via smartphone, Neu Health is built on the Oxford Discovery Cohort, one of the world’s largest longitudinal datasets on Parkinson’s, with 10+ years of real-world patient tracking
Groundbreaking platform analyzes cognitive and motor function through structured, at-home assessments, generating digital biomarkers and predictive scores to support early detection and decision-making
Now live in the U.S., Neu Health gives clinicians and families a way to detect and monitor neurological decline between appointments, replacing crisis-driven care with early insight, and a chance to act while there’s still time to adapt, respond and preserve quality of life
BOSTON, July 29, 2025 — Neu Health, a precision neurology platform for Parkinson’s and dementia, today announced FDA 510(k) clearance for its smartphone-based tremor measurement module, designed to quantify tremor in adults with mild to moderate Parkinson’s disease. This marks the first known fully phone-based system, with no wearable or in-clinic hardware, for measuring motor symptoms in Parkinson’s care.
The clearance represents one part of a broader groundbreaking platform that helps clinicians and families monitor cognitive and motor changes from home. Built for everyday use on a standard smartphone, Neu guides Parkinson’s and dementia patients through short, structured tasks that analyze speech, movement and memory, generating predictive biomarkers that flag early signs of neurological decline weeks or even months before traditional tools detect a problem. Neu’s FDA clearance for Parkinson’s tremor measurement coincides with its formal entry into the U.S. market, where the platform is already live for Parkinson’s care at Mass General Brigham.
Parkinson’s disease affects more than one million Americans today, and that number is projected to grow 20% by 2030. Dementia impacts over 6 million people in the US, with global cases expected to triple by mid-century. While the number of patients increases, neurologist shortages strain health systems nationwide. With the oldest baby boomers now turning 79, providers desperately need scalable, humane brain care. However, most patients go six months or longer between neurology appointments, often living their lives without any structured support. During those silent months, symptoms continue to progress, causing people to fall, hallucinate and miss medications. Caretakers, including family and friends, often have no objective way to gauge what’s actually happening, because the reality is tangled in a web of symptoms, daily variability and the complexity of life itself. Only when a hospitalization forces serious action does the full severity of disease progression come into focus.
Built on over a decade of research at the University of Oxford and already validated across NHS Trusts in the UK, Neu brings proactive, high-resolution brain care into the home. Designed to detect deterioration before it spirals out of control, the platform guides patients through a series of short assessments that measure changes in voice, memory, movement, and cognition. These subtle shifts are often missed in clinic but are captured through Neu’s repeatable, research-validated measurements. Clinicians receive scores that help them prioritize care, detect escalation early, adjust existing treatments and justify more advanced interventions, all without adding administrative burden.
Platform highlights:
Requires no additional hardware or in-clinic setup; patients use their own phones at home
Integration with major EHRs and support for Remote Therapeutic Monitoring (RTM) billing
Passive and active smartphone sensors track changes in cognition, movement and speech
Generates composite scores structured insights aligned to clinical decision-making
Backed by 10+ years of real-world patient data
Co-Founder & Chief Executive Officer - Caroline Cake
“For too long, we’ve treated brain health reactively, standing by until someone is visibly declining before stepping in. We can no longer wait for accidents to happen to justify the next level of care for our loved ones,” said Caroline Cake, CEO and co-founder of Neu Health. “Neu offers health systems a new path forward, where high-frequency monitoring, predictive insights and home-based tools expand the reach of neurologists, relieve pressure on frontline staff and raise the standard of care for millions of patients and families.”
Neu’s impact goes beyond convenience. By generating structured, high-frequency data between visits, the platform helps care teams triage patients based on risk, track disease progression over time, and intervene earlier, often before visible symptoms appear. This insight supports more confident decision-making and documentation, unlocking opportunities for proactive care and reimbursement. With seamless integration into major EHR systems, Neu fits directly into clinical workflows, helping neurologists, geriatricians and primary care teams manage growing patient volumes without increasing administrative burden or headcount.
Co-Founder & Chief Medical Officer - Kinan Muhammed
“People often overlook voice or gait changes because they assume they’re minor, but they’re among the earliest and most actionable signals of neurological decline,” said Dr. Kinan Muhammed, Neu Health’s co-founder and Chief Medical Officer. “By capturing these subtle shifts longitudinally and objectively, Neu allows us to anticipate deterioration, personalize treatment and reduce the burden on patients, caregivers and care teams alike.”
Early findings from Neu’s UK deployments suggest the platform may detect neurological changes earlier than traditional assessments; in some cases, up to 18 months ahead. Its digital phenotyping methodology has been validated across peer-reviewed studies published in Neurology and the Journal of Neurology, Neurosurgery & Psychiatry (JNNP).
Neu is in active discussions with additional health systems and payer partners to scale its reach across the U.S. The company’s clinical foundation and seamless, smartphone-based delivery make it a powerful new option for expanding access to specialist-level brain care. By eliminating the need for in-clinic setup or expensive hardware, Neu is also well-suited to serve communities left behind by traditional models, including rural areas, lower-income families and populations with limited neurologist access.
About Neu Health
Neu Health is pioneering a new model of precision neurology for Parkinson’s and dementia: care that is proactive, compassionate, and designed for the realities of everyday life. Built on one of the most advanced longitudinal datasets in Parkinson’s care — the Oxford Parkinson’s Disease Centre Discovery Cohort — Neu’s smartphone-based platform turns structured at-home assessments into actionable insights, enabling clinicians to detect decline earlier and act before symptoms escalate. The technology analyzes speech, movement, memory, and cognition in just minutes a day, using trained models to generate predictive scores and digital biomarkers that inform treatment and care. Neu is working with leading U.S. health systems to expand access, ease workforce strain, and set a new standard for brain health monitoring. To learn more, visit https://neu.health.
###
Media Contact: